INHIBITION OF VESSEL ALLOGRAFT-REJECTION BY ENDOTHELIAL REMOVAL - MORPHOLOGICAL AND ULTRASTRUCTURAL-CHANGES

[1] MAJOR HISTOCOMPATIBILITY COMPLEX - GENETICS AND BIOLOGY .1. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (15) : 806 - 813

[2] DIFFERENTIAL FUNCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN T-LYMPHOCYTE ACTIVATION [J]. NATURE, 1976, 259 (5541) : 273 - 281

[3] CYTO-TOXIC LYMPHOCYTES-T HOW DO THEY FUNCTION [J]. IMMUNOLOGICAL REVIEWS, 1983, 72 : 5 - 42

[4] CLOWES AW, 1986, LAB INVEST, V54, P295

[5] COLE CW, 1984, SURG FORUM, V35, P440

[6] DOI K, 1979, PLAST RECONSTR SURG, V64, P613, DOI 10.1097/00006534-197964050-00003

[7] THE MICROVASCULATURE IS THE CRITICAL TARGET OF THE IMMUNE-RESPONSE IN VASCULARIZED SKIN ALLOGRAFT-REJECTION [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (05) : 280 - 284

[8] FISHMAN JA, 1975, LAB INVEST, V32, P339

[9] FORBES RDC, 1983, AM J PATHOL, V111, P184

[10] FORBES RDC, 1982, AM J PATHOL, V106, P378

[1] MAJOR HISTOCOMPATIBILITY COMPLEX - GENETICS AND BIOLOGY .1. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (15) : 806 - 813

[2] DIFFERENTIAL FUNCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN T-LYMPHOCYTE ACTIVATION [J]. NATURE, 1976, 259 (5541) : 273 - 281

[3] CYTO-TOXIC LYMPHOCYTES-T HOW DO THEY FUNCTION [J]. IMMUNOLOGICAL REVIEWS, 1983, 72 : 5 - 42

[4] CLOWES AW, 1986, LAB INVEST, V54, P295

[5] COLE CW, 1984, SURG FORUM, V35, P440

[6] DOI K, 1979, PLAST RECONSTR SURG, V64, P613, DOI 10.1097/00006534-197964050-00003

[7] THE MICROVASCULATURE IS THE CRITICAL TARGET OF THE IMMUNE-RESPONSE IN VASCULARIZED SKIN ALLOGRAFT-REJECTION [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 74 (05) : 280 - 284

[8] FISHMAN JA, 1975, LAB INVEST, V32, P339

[9] FORBES RDC, 1983, AM J PATHOL, V111, P184

[10] FORBES RDC, 1982, AM J PATHOL, V106, P378